Related Experiment Video
Updated: Dec 2, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
Published on: October 21, 2022
Circular RNAs in liver diseases: Mechanisms and therapeutic targets
Li-Yun Fu1, Shu-Wei Wang2, Meng-Yuan Hu2
1Department of Infection and Hepatology, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo 315010, China; Ningbo Institute of Life and Health Industry, University of Chinese Academy of Science, Ningbo 315010, China; Key Laboratory of Diagnosis and Treatment of Digestive System Tumors of Zhejiang Province, Ningbo 315010, China; Department of Biochemistry and Molecular Biology, Zhejiang Key Laboratory of Pathophysiology, Medical School of Ningbo University, Ningbo 315211, China.
Abstract:
Circular RNAs (circRNAs) are formed from the genome through diverse back splicing and feature the closed loop. circRNAs are widely available in a variety of cells and characterized by conservation, structural stability, high abundance and tissue-specific or developmental-specific expression. Recent studies have shown that circRNAs are closely related to liver diseases, such as metabolic-associated fatty liver disease, hepatitis, liver cirrhosis and hepatocellular carcinoma. circRNAs play an important role in the progression of liver diseases, are potential diagnostic and prognostic markers, and have translational value in therapy. This article reviews the research on circRNAs in liver diseases, with a view to providing a theoretical basis and new ideas for future research and treatment of liver diseases.
Insights
Circular RNAs (circRNAs), stable molecules with unique loops, are linked to various liver diseases. Research highlights their role in disease progression and potential as diagnostic markers and therapeutic targets.
Area of Science:
- Molecular Biology
- Genetics
- Hepatology
Background:
- Circular RNAs (circRNAs) are covalently closed RNA molecules derived from precursor mRNA.
- They exhibit high stability, abundance, and tissue-specific expression patterns.
- Emerging evidence implicates circRNAs in the pathogenesis of diverse liver diseases.
Purpose of the Study:
- To review the current research on the role of circRNAs in liver diseases.
- To explore the diagnostic and prognostic potential of circRNAs.
- To discuss the therapeutic implications of circRNAs in liver disease treatment.
Main Methods:
- Literature review of studies investigating circRNAs in liver diseases.
- Analysis of circRNA expression patterns and functional roles.
- Evaluation of circRNAs as biomarkers and therapeutic targets.
Main Results:
- CircRNAs are implicated in metabolic-associated fatty liver disease, hepatitis, liver cirrhosis, and hepatocellular carcinoma.
- These molecules play significant roles in the progression of liver pathologies.
- CircRNAs demonstrate potential as diagnostic and prognostic indicators.
Conclusions:
- Circular RNAs are crucial players in liver disease development and progression.
- CircRNAs hold promise as valuable biomarkers for liver disease diagnosis and prognosis.
- Targeting circRNAs may offer novel therapeutic strategies for liver diseases.
Related Concept Videos
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Types of RNA
RNA Performs Diverse...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...

